Home / Erythromycin / Canada
CA ATC J01FA01 · updated 2 Nov 2026
Erythromycin shortage in Canada
Is there an Erythromycin shortage in Canada?
Yes. As of 2 Nov 2026, 2 Erythromycin products are reported short in Canada. The company estimate for the return is 30 Apr 2027. Main reason: active ingredient shortage.
Also short in Germany, Italy, Spain, Ireland, Belgium, Norway, Sweden, New Zealand, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | ERYTHROCIN I.V. (10 vials) anticipated | AMDIPHARM LIMITED | 31 Dec 2026 | 30 Apr 2027 | Active ingredient shortage Shortage of an active ingredient |
| CA | ERYTHROCIN I.V. (10 vials) anticipated | AMDIPHARM LIMITED | 31 Mar 2027 | 30 Apr 2027 | Active ingredient shortage Shortage of an active ingredient |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.